PDS Biotechnology Corp Payments of Stock Issuance Costs
PDS Biotechnology Corp (PDSB) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2018-03-01
- PDS Biotechnology Corp payments of stock issuance costs for the quarter ending 2017-12-31 was $0.00.
- PDS Biotechnology Corp payments of stock issuance costs for the quarter ending 2017-09-30 was $0.00.
- PDS Biotechnology Corp payments of stock issuance costs for the quarter ending 2017-06-30 was $0.00.
- PDS Biotechnology Corp payments of stock issuance costs for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp payments of stock issuance costs for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- PDS Biotechnology Corp payments of stock issuance costs for fiscal 2016 was $544.77K, a 61.17% decline from fiscal 2015.
- PDS Biotechnology Corp payments of stock issuance costs for fiscal 2015 was $1.40M, a 3.80% increase from fiscal 2014.
- PDS Biotechnology Corp payments of stock issuance costs for fiscal 2014 was $1.35M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $0.00 10-Q · filed 2017-08-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-03 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | -$4.41K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | -$4.41K derived: sum of 3 quarters · filed 2018-03-01 | $544.77K 10-K · filed 2018-03-01 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$4.41K derived: sum of 2 quarters · filed 2017-11-01 | $544.77K 10-Q · filed 2017-11-01 | $1.47M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$4.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $544.77K 10-Q · filed 2017-08-01 | $1.47M derived: sum of 3 quarters · filed 2018-03-01 | $1.71M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $549.18K 10-Q · filed 2017-05-03 | $1.48M derived: sum of 2 quarters · filed 2018-03-01 | $1.71M derived: sum of 3 quarters · filed 2018-03-01 | $1.90M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $928.49K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.16M derived: sum of 2 quarters · filed 2018-03-01 | $1.35M derived: sum of 3 quarters · filed 2018-03-01 | $1.40M 10-K · filed 2018-03-01 |
| 2015-09-30 | $234.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $423.47K derived: sum of 2 quarters · filed 2016-11-01 | $474.36K 10-Q · filed 2016-11-01 | $1.03M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $189.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $240.32K 10-Q · filed 2016-08-03 | $794.98K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $50.89K 10-Q · filed 2016-05-03 | $605.55K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $554.66K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $1.35M 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $796.79K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |